~65% of all Academic Medical Centers in the US are connected to Tempus
50%+ of oncologists in the US connected to Tempus through sequencing, clinical trial matching, and research-enabled partnerships
95% of the top 20 pharma oncology companies partner with Tempus
200+ biopharma partnerships
~6,000,000 de-identified research records to power scientific discovery to improve patient outcomes
30,000+ patients have been identified for potential enrollment into clinical trials in our network
200+ petabytes of data